NCT01812382 - Retapamulin Microdialysis Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 2, 2014

Primary Completion Date

May 27, 2014

Study Completion Date

May 27, 2014

Conditions

Skin Infections, Bacterial

Interventions

DRUG

Retapamulin Microdialysis

After a 30 minutes equilibration period of the microdialysis procedure/infusion with normal saline solution, 50nanogram (ng)/mL Retapamulin injectable solution will be infused at a flow rate of 1.5 microliter/minute over a period of 90 minutes. The total dose perfused for each of the 3 microdialysis tubes will be 6.75ng.

Trial Locations (1)

32610

GSK Investigational Site, Gainesville